10 CFR 35.2063 - Records of dosages of unsealed byproduct material for medical use.

§ 35.2063 Records of dosages of unsealed byproduct material for medical use.
(a) A licensee shall maintain a record of dosage determinations required by § 35.63 for 3 years.
(b) The record must contain—
(1) The radiopharmaceutical;
(2) The patient's or human research subject's name, or identification number if one has been assigned;
(3) The prescribed dosage, the determined dosage, or a notation that the total activity is less than 1.1 MBq (30 µCi);
(4) The date and time of the dosage determination; and
(5) The name of the individual who determined the dosage.

Title 10 published on 2014-01-01

no entries appear in the Federal Register after this date.

This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.

This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].

It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.

United States Code

Title 10 published on 2014-01-01

The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 10 CFR 35 after this date.

  • 2014-09-22; vol. 79 # 183 - Monday, September 22, 2014
    1. 79 FR 56524 - Medical Use of Byproduct Material—Medical Event Definitions, Training and Experience, and Clarifying Amendments; Correction
      GPO FDSys XML | Text
      Proposed rule; correction.
      This correction is effective on September 22, 2014. Submit comments on the information collection aspects of the proposed rule by October 22, 2014.
      10 CFR Parts 30, 32 and 35